Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Explore practical ways to minimize the financial impact of budgeting mistakes and implement safeguards to protect money and goals.
22,127 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
As Nvidia prepares to report earnings in May, investors weigh AI momentum against valuation. This practical guide exp...
Two senior researchers depart the Ethereum Foundation, intensifying leadership churn. Market watchers split on whethe...
Oil climbs above $100 per barrel as tensions surface around Iran. Gas prices push near $4.60 a gallon ahead of Memori...
Mortgage REITs like AGNC regularly issue new shares to manage leverage and fund income opportunities. This article ex...
Rising equity in rental properties creates powerful choices. This guide walks you through when to keep, when to sell,...
David Cordani is stepping aside as Cigna's CEO to become executive chairman, ending a 17‑year run that propelled the ...
Tesla surprised markets with two stock splits in the early 2020s. Could a third split arrive in 2026? This guide expl...
Prediction-market traders are pricing a US edge after Balogun’s clearance to play in the World Cup round-of-16. Marke...
Markets paused to digest a major memory-chip move while the Nasdaq Composite held steady. This article breaks down wh...
Rivian stock fell first half 2026 as a mix of delivery updates, new model momentum, and macro headwinds shaped invest...